Sponsor:
SpyGlass Pharma, Inc.
Code:
NCT07218796
Conditions
Cataract
Glaucoma
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Bimatoprost Implant System
SpyGlass IOL
Timolol Maleate Ophthalmic Solution, 0.5%
Commercial IOL
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-28. This information was provided to ClinicalTrials.gov by SpyGlass Pharma, Inc. on 2025-10-20.